נגישות
menu      
Advanced Search
Syntax
Search...
Volcani treasures
About
Terms of use
Manage
Community:
אסיף מאגר המחקר החקלאי
Powered by ClearMash Solutions Ltd -
Colonic tumor membrane associated glycoprotein: isolation of antigenically active peptides after chemical cleavage
Year:
1977
Source of publication :
Journal of Immunology
Authors :
Eshdat, Yuval
;
.
Volume :
119
Co-Authors:
Leung, J.P., Dept. Pathol., Yale Univ. Sch. Med., New Haven, Conn. 06510, United States
Eshdat, Y., Dept. Pathol., Yale Univ. Sch. Med., New Haven, Conn. 06510, United States
Marches, V.T., Dept. Pathol., Yale Univ. Sch. Med., New Haven, Conn. 06510, United States
Facilitators :
From page:
664
To page:
670
(
Total pages:
7
)
Abstract:
A membrane-associated glycoprotein fraction, referred to as CEA-M was isolated from human colonic tumor tissue by sodium dodecyl sulfate extraction of membrane fragments followed by wheat germ agglutinin affinity chromatography, Bio-Gel A-1.5 gel filtration and preparative slab gel electrophoresis. With a m.w. of approximately 200,000, isoelectric point of about 4.2 and carbohydrate: protein ratio of 2:1, this glycoprotein has physiocochemical and antigenic similarities to carcinoembryonic antigen, CEA. Immunochemical studies have shown that antiserum developed for this glycoprotein possesses relative specificity for human colonic carcinomas. Chemical cleavage of this glycoprotein by 2-nitro-5-thiocyanobenzoic acid resulted in three major Coomassie Blue and two periodic acid Schiff stainable fragments (one of which stains with both). It was found that one of the glycopeptides, labeled as TA, isolated by affinity and covalent chromatography, contained 77% carbohydrates and possessed antigenic determinants recognized by at least 70% of the antibody population raised against the total glycoprotein fraction; purified antibodies to this region of the molecule seem promising for the development of a specific assay for gastrointestinal tumors.
Note:
Related Files :
Antibodies, Neoplasm
antigen antibody reaction
Benzoates
Carbohydrate
cell membrane
colon carcinoma
Show More
Related Content
More details
DOI :
Article number:
Affiliations:
Database:
Scopus
Publication Type:
article
;
.
Language:
English
Editors' remarks:
ID:
18554
Last updated date:
02/03/2022 17:27
Creation date:
16/04/2018 23:22
You may also be interested in
Scientific Publication
Colonic tumor membrane associated glycoprotein: isolation of antigenically active peptides after chemical cleavage
119
Leung, J.P., Dept. Pathol., Yale Univ. Sch. Med., New Haven, Conn. 06510, United States
Eshdat, Y., Dept. Pathol., Yale Univ. Sch. Med., New Haven, Conn. 06510, United States
Marches, V.T., Dept. Pathol., Yale Univ. Sch. Med., New Haven, Conn. 06510, United States
Colonic tumor membrane associated glycoprotein: isolation of antigenically active peptides after chemical cleavage
A membrane-associated glycoprotein fraction, referred to as CEA-M was isolated from human colonic tumor tissue by sodium dodecyl sulfate extraction of membrane fragments followed by wheat germ agglutinin affinity chromatography, Bio-Gel A-1.5 gel filtration and preparative slab gel electrophoresis. With a m.w. of approximately 200,000, isoelectric point of about 4.2 and carbohydrate: protein ratio of 2:1, this glycoprotein has physiocochemical and antigenic similarities to carcinoembryonic antigen, CEA. Immunochemical studies have shown that antiserum developed for this glycoprotein possesses relative specificity for human colonic carcinomas. Chemical cleavage of this glycoprotein by 2-nitro-5-thiocyanobenzoic acid resulted in three major Coomassie Blue and two periodic acid Schiff stainable fragments (one of which stains with both). It was found that one of the glycopeptides, labeled as TA, isolated by affinity and covalent chromatography, contained 77% carbohydrates and possessed antigenic determinants recognized by at least 70% of the antibody population raised against the total glycoprotein fraction; purified antibodies to this region of the molecule seem promising for the development of a specific assay for gastrointestinal tumors.
Scientific Publication
You may also be interested in